EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Activity
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

153 hedge funds and large institutions have $337M invested in Eagle Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 47 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
153
Holders Change
-10
Holders Change %
-6.13%
% of All Funds
2.65%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
63
Reduced
47
Closed
32
Calls
$3.6M
Puts
–
Net Calls
+$3.6M
Net Calls Change
+$3.6M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$65.5M
2
State Street
2
State Street
Massachusetts
$26.7M
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$8.22M
4
Citadel Advisors
4
Citadel Advisors
Florida
$4.89M
5
TCM
5
Tang Capital Management
California
$3.14M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$4.35M
2
FP
2
Foundry Partners
Minnesota
$0
3
GC
3
Globeflex Capital
California
$0
4
Allspring Global Investments
4
Allspring Global Investments
North Carolina
$2.33M
5
E
5
Ergoteles
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AS
176
Altshuler Shaham
Israel
– -$27K -617 Closed
CAPTRUST Financial Advisors
177
CAPTRUST Financial Advisors
North Carolina
– -$20K -439 Closed
SWA
178
Sutton Wealth Advisors
Florida
– -$16.5K -371 Closed
VCM
179
Versant Capital Management
Arizona
– -$1K -12 Closed
FSWA
180
Financial Synergies Wealth Advisors
Texas
– -$223 -5 Closed
4 5 6 7
8